Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 45, 2017 - Issue 2
Submit an article Journal homepage
706
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

The use of experimental design in the optimization of risperidone biodegradable nanoparticles: in vitro and in vivo study

Ali F. A. AlzubaidiDepartment of Pharmaceutics and Industrial Pharmacy Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia;
,
Abdel-Raheem M. El-HelwDepartment of Pharmaceutics and Industrial Pharmacy Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia;
,
Tarek A. AhmedDepartment of Pharmaceutics and Industrial Pharmacy Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ;Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt;
&
Osama A. A. AhmedDepartment of Pharmaceutics and Industrial Pharmacy Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ;Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia University, Minia, EgyptCorrespondence[email protected]
Pages 313-320 | Received 01 Jan 2016, Accepted 25 Jan 2016, Published online: 21 Feb 2016

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Rehab Abdelmonem, Hadel A. Abo El-Enin, Ghada Abdelkader & Mohamed Abdel-Hakeem. (2023) Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment. Drug Delivery 30:1.
Read now
Madeleine S. A. Tan, Harendra S Parekh, Preeti Pandey, Dan J. Siskind & James R. Falconer. (2020) Nose-to-brain delivery of antipsychotics using nanotechnology: a review. Expert Opinion on Drug Delivery 17:6, pages 839-853.
Read now
Rajalakshmi Rukmangathen, Indira Muzib Yallamalli & Prasanna Raju Yalavarthi. (2019) Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Drug Development and Industrial Pharmacy 45:8, pages 1342-1350.
Read now
Samane Bayrami, Zahra Esmaili, SeyedAhmad SeyedAlinaghi, Saeed Reza Jamali Moghadam, Sepide Bayrami, Hamid Akbari Javar, Morteza Rafiee Tehrani & Farid Abedin Dorkoosh. (2019) Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation. Pharmaceutical Development and Technology 24:2, pages 176-188.
Read now
Nika Bahari Javan, Leila Rezaie Shirmard, Nersi Jafary Omid, Hamid Akbari Javar, Morteza Rafiee Tehrani & Farid Abedin Dorkoosh. (2016) Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide. Journal of Microencapsulation 33:5, pages 460-474.
Read now

Articles from other publishers (11)

Marwa H. Abdallah, Hemat El-Sayed El-Horany, Hanan M. El-Nahas & Tarek M. Ibrahim. (2023) Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route. Pharmaceutics 15:11, pages 2521.
Crossref
Shaymaa Wagdy El-Far, Hadel A. Abo El-Enin, Ebtsam M. Abdou, Ola Elsayed Nafea & Rehab Abdelmonem. (2022) Targeting Colorectal Cancer Cells with Niosomes Systems Loaded with Two Anticancer Drugs Models; Comparative In Vitro and Anticancer Studies. Pharmaceuticals 15:7, pages 816.
Crossref
Annu, Sanjula Baboota & Javed Ali. (2021) In vitro appraisals and ex vivo permeation prospect of chitosan nanoparticles designed for schizophrenia to intensify nasal delivery. Polymer Bulletin 79:4, pages 2263-2285.
Crossref
Hadel A. Abo El-Enin, Rasha E. Mostafa, Marwa F. Ahmed, Ibrahim A. Naguib, Mohamed A. Abdelgawad, Mohammed M. Ghoneim & Ebtsam M. Abdou. (2022) Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms. Pharmaceutics 14:2, pages 410.
Crossref
Maria Camilla Bergonzi, Anna Rita Bilia & Elisa Landucci. (2022) Applications of innovative technologies to the delivery of antipsychotics. Drug Discovery Today 27:2, pages 401-421.
Crossref
Yana Zorkina, Olga Abramova, Valeriya Ushakova, Anna Morozova, Eugene Zubkov, Marat Valikhov, Pavel Melnikov, Alexander Majouga & Vladimir Chekhonin. (2020) Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 25:22, pages 5294.
Crossref
Allan Radaic & Daniel Martins-de-Souza. (2020) The state of the art of nanopsychiatry for schizophrenia diagnostics and treatment. Nanomedicine: Nanotechnology, Biology and Medicine 28, pages 102222.
Crossref
Hibah M. Aldawsari, Usama A. Fahmy, Fathy Abd-Allah & Osama A. A. Ahmed. (2020) Formulation and Optimization of Avanafil Biodegradable Polymeric Nanoparticles: A Single-Dose Clinical Pharmacokinetic Evaluation. Pharmaceutics 12:6, pages 596.
Crossref
Lamya H. Al-Wahaibi, Muneera S. M. Al-Saleem, Osama A. A. Ahmed, Usama A. Fahmy, Nabil A. Alhakamy, Basma G. Eid, Ashraf B. Abdel-Naim, Wael M. Abdel-Mageed, Maha M. AlRasheed & Gamal A. Shazly. (2020) Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells. International Journal of Molecular Sciences 21:11, pages 4138.
Crossref
Annu, Saleha Rehman, Shadab Md, Sanjula Baboota & Javed Ali. (2019) Analyzing Nanotheraputics-Based Approaches for the Management of Psychotic Disorders. Journal of Pharmaceutical Sciences 108:12, pages 3757-3768.
Crossref
Osama A. A. Ahmed. (2018) Development and single dose clinical pharmacokinetics investigation of novel zein assisted- alpha lipoic acid nanoencapsulation of vardenafil. Scientific Reports 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.